FindMyKOL
Clinical trialNCT00724516CompletedInterventional

Evaluation Of A Novel Breast Compression Paddle For Wire Localization In Mammography

NCT00724516 is an interventional trial sponsored by University of Michigan. As of 21 Nov 2026, it is completed. It studies Biopsy, Needle and Mammography. The registry lists an enrollment of 10 participants at 1 site in 1 country. The registry lists a start date of 30 Jun 2007 and a primary completion date of 31 Dec 2009.

SponsorUniversity of Michigan →Enrollment10Biopsy, NeedleMammography
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT00724516
FieldValue
Registry IDNCT00724516
StatusCompleted
Study typeInterventional trial
Lead sponsorUniversity of Michigan
Enrollment10
Registered sites1
Countries1
ConditionsBiopsy, Needle and Mammography
Start30 Jun 2007
Primary completion31 Dec 2009
Study completion31 Dec 2010
Last update posted6 Jul 2017

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the functionality of a new breast compression paddle used in mammography for wire localization.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Michigan, United States1 site
  • University of Michigan Health System

    Ann Arbor

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichigan: 1 siteMI1New YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT00724516

Each answer restates registry values shown on this page.

What is NCT00724516?

NCT00724516 is an interventional trial sponsored by University of Michigan. It studies Biopsy, Needle and Mammography.

Who leads NCT00724516?

The registry names Caroline Blane, M.D. (principal investigator, University of Michigan Hospital) as the overall official.

Where does NCT00724516 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT00724516 end?

The registry lists a primary completion date of 31 Dec 2009 and a study completion date of 31 Dec 2010. The sponsor last updated the record on 6 Jul 2017.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.